Literature DB >> 2553245

Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma.

M H Chang1, D S Chen, H C Hsu, H Y Hsu, C Y Lee.   

Abstract

Fifty-one children, aged between 3 and 16 years, were diagnosed to have hepatocellular carcinoma (HCC) in the last 15 years. Serum hepatitis B surface antigen (HBsAg) was positive in all the latter 34 HCC children checked by radioimmunoassay, and was positive in five of the 17 earlier HCC children studied by double immunodiffusion method. Serum HBsAg was studied in 31 mothers of the latter 33 HCC children, including two pairs of affected siblings and was positive in 29 (94%). The positive rate was much higher than that (50%) of the mothers of control HBsAg carrier children (P less than 0.001). The serum HBsAg positive rate was also higher in the siblings of HCC children than that of the control group. On the contrary, the serum HBsAg positive rate was not different between the fathers of HCC children and that of the control group. Our observation demonstrated that transmission of hepatitis B virus from the mothers during the perinatal period or early childhood is the most important mode of hepatitis B virus infection in HCC children in Taiwan.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553245     DOI: 10.1002/1097-0142(19891201)64:11<2377::aid-cncr2820641130>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Paediatric oncology in developing countries.

Authors:  G Prindull
Journal:  Eur J Pediatr       Date:  1991-08       Impact factor: 3.183

2.  Natural history and clinical management of chronic hepatitis B virus infection in children.

Authors:  Mei-Hwei Chang
Journal:  Hepatol Int       Date:  2008-03-06       Impact factor: 6.047

3.  Clinical characteristics and outcome of hepatocellular carcinoma in children and adolescents.

Authors:  Xu-Feng Zhang; Xue-Min Liu; Tao Wei; Chang Liu; Mu-Xing Li; Zhi-Da Long; Yi Lv
Journal:  Pediatr Surg Int       Date:  2013-06-22       Impact factor: 1.827

Review 4.  Prevention of hepatitis B.

Authors:  Mei-Hwei Chang; Ding-Shinn Chen
Journal:  Cold Spring Harb Perspect Med       Date:  2015-03-02       Impact factor: 6.915

5.  Familial clustering of hepatocellular carcinoma in HBsAg-positive patients in the United States.

Authors:  Myron John Tong; Thatcher Thi Huynh; Surachate Siripongsakun
Journal:  Hepatol Int       Date:  2013-07-17       Impact factor: 6.047

6.  Family history influences the early onset of hepatocellular carcinoma.

Authors:  Chung-Hwa Park; Seung-Hee Jeong; Hyeon-Woo Yim; Jin Dong Kim; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 7.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

8.  Should a booster dose be administered in children after mass immunization for hepatitis B?

Authors:  Selma Tosun; Serol Deveci; Yunus Kaplan; Erhun Kasirga
Journal:  Hepat Mon       Date:  2011-06       Impact factor: 0.660

Review 9.  Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review.

Authors:  Yusuke Shimakawa; Hong-Jing Yan; Naho Tsuchiya; Christian Bottomley; Andrew J Hall
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

10.  Childhood cancers: what is a possible role of infectious agents?

Authors:  Kenneth Alibek; Assel Mussabekova; Ainur Kakpenova; Assem Duisembekova; Yeldar Baiken; Bauyrzhan Aituov; Nargis Karatayeva; Samal Zhussupbekova
Journal:  Infect Agent Cancer       Date:  2013-12-10       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.